NXS — Material Events
ASX:NXS · 10 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Next Science Suspended from ASX Over Operational ShortfallHigh
Next Science Limited suspended from ASX trading over insufficient operations
2 Jan 2026
·Suspension from Quotation
·85
Next Science Boosts Sales, Completes $50M Asset Sale, Eyes Shareholder PayoutHigh
Next Science reports Q3 sales growth, completes US$50m asset sale, and plans shareholder return
30 Oct 2025
·Appendix 4C & Quarterly Activity Report
·85
Next Science Narrows Loss 20% Amid $50M Asset Sale to OSARTISHigh
Next Science reports H1 2025 loss narrowing 20%, agrees to USD 50M asset sale to OSARTIS
29 Aug 2025
·Appendix 4D Interim Financial Report
·85
Next Science Completes $50M Asset Sale, Eyes $30M Return to ShareholdersMedium
Next Science completes US$50m asset sale to OSARTIS, plans shareholder return of net proceeds
16 Sept 2025
·Asset Sale Completion
·80
Next Science Narrows Losses as Asset Sale Clears Path ForwardMedium
Next Science reports 1H FY25 results with improved EBITDA loss and asset sale approved
29 Aug 2025
·Half Year Financial Report
·75
Next Science Moves to Delist After Asset Sale, Plans Capital ReturnMedium
Next Science to Voluntarily Delist from ASX After Asset Sale, Proposes Capital Return and Winding Up
23 Dec 2025
·Delisting Announcement
·75
Next Science Navigates Sales Dip Amid $50M Asset Sale DealMedium
Next Science reports 10% sales decline, enters US$50m asset sale agreement
31 July 2025
·Appendix 4C & Quarterly Activity Report
·75
Next Science Moves to Return $30M to Shareholders After Asset SaleMedium
Next Science to return capital post asset sale; CEO and CFO step down
28 Jan 2026
·Appendix 4C & Quarterly Activity Report
·70
Next Science Secures ASX Waiver to Return Capital Post $50M Asset SaleMedium
Next Science granted ASX waiver to proceed with capital return after asset sale
23 Dec 2025
·ASX Waiver Announcement
·70
Next Science Sets New Date for Capital Return Amid Delisting PlansMedium
Next Science delays cash return of capital payment to 10 February 2026 following asset sale
30 Jan 2026
·Capital Return
·60
No articles in this tier for the last 12 months.